PAID 1.0 in Practice: A Brief Clarification Regarding its Possibilities and Limitations

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.29, Iss.6, 2011-06, pp. : 545-547

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Possibilities and limitations of capillary electropherosis in pharmaceutical analysis

By Borst C. Belal F. Holzgrabe U.

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 68, Iss. 7, 2013-07 ,pp. : 526-530

Govi-Verlag

Access to resources Recommend Favorite

Evaluation of Novel Biomarkers of Acute Kidney Injury: The Possibilities and Limitations

Current Medicinal Chemistry, Vol. 23, Iss. 19, 2016-07 ,pp. : 1981-1997

Bentham Science Publishers

Access to resources Recommend Favorite

Caveats Regarding the Use of IL-10 and IL-10 Antagonist as Immunotherapeutic Factors

Letters in Drug Design & Discovery, Vol. 4, Iss. 7, 2007-01 ,pp. : 487-495

Bentham Science Publishers

Access to resources Recommend Favorite

Most cited articles in the Archives of Toxicology: the debate about possibilities and limitations of in vitro toxicity tests and replacement of in vivo studies

By Bolt H.

Archives of Toxicology, Vol. 82, Iss. 12, 2008-12 ,pp. : 881-883

Springer Publishing Company

Access to resources Recommend Favorite

Developing Immunologically Inert Adeno-Associated Virus (AAV) Vectors for Gene Therapy: Possibilities and Limitations

Current Pharmaceutical Biotechnology, Vol. 14, Iss. 12, 2013-01 ,pp. : 1072-1082

Bentham Science Publishers

Access to resources Recommend Favorite